Joslin Diabetes Center Announces Alliance with Johnson & Johnson Innovation to Identify Exercise-Related Drug Targets to Improve Diabetes Management:
BOSTON (October 9, 2013) – Joslin Diabetes Center announces a research and development alliance with Johnson & Johnson Innovation and its affiliate Janssen Research & Development, LLC, to identify and advance early-stage, novel therapeutic projects for potential for commercialization and product development. The first joint project selected in the alliance will focus on identifying exercise-related drug targets for developing new diabetes treatments.
Joslin Partners with Pfizer and Lilly to Develop Ways to Predict and Treat Kidney Failure in Type 2 Diabetes Patients :
BOSTON (October 4, 2013) – Joslin Diabetes Center’s Office of Commercialization and Ventures, today announced it is collaborating with Eli Lilly and Company and Pfizer Inc. which will enable Joslin and both companies to accelerate research aimed at predicting kidney failure in patients with type 2 diabetes and developing potential ways to treat and prevent this complication of diabetes.
Collaboration between Sanofi and Joslin Diabetes Center to focus on new drugs for diabetes :
PARIS (June 19, 2012) Sanofi (EURONEXT: SAN and NYSE: SNY) and the Joslin Diabetes Center, a teaching and research affiliate of Harvard Medical School, today announced a new collaboration to promote the development of new medicines for the treatment of diabetes and related disorders. The collaboration was unveiled at the 2012 Bio International Convention in Boston, Mass.
EFK Diagnostics and Joslin Sign Licensing Agreement for Kidney Markers:
(July 17, 2013)- EKF Diagnostics Holdings plc (AIM: EKF), a worldwide manufacturer of point of care in-vitro diagnostic devices, announces that it has signed an exclusive license agreement with the Joslin Diabetes Center (“Joslin”), a teaching, research and clinical care affiliate of Harvard Medical School, to license certain novel kidney biomarker technology.
Page last updated: December 05, 2013